NIH-funded research NIH-funded research

Flexible methadone take-home dosing to keep people in treatment

Official title: Leveraging regulatory flexibility for methadone take-home dosing to improve retention in treatment for opioid use disorder: A stepped-wedge randomized trial to facilitate clinic level changes

Funded at New York University School of Medicine · NIH-11396986 · Data updated 2026-11-12

A large, real-world study tests whether making take-home methadone more flexible helps people stay in treatment for opioid use disorder.

More Opioid Use Disorder research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2022
Project endAugust 31, 2027
Funding year2026
Award (this year)$1,066,324
NIH project number5R33DA057683-05
Project IDNIH-11396986 on NIH RePORTER

Who could benefit from this research

Could help

Adults receiving methadone treatment for opioid use disorder at participating clinics who are eligible for take-home dosing.

Less likely to help

Patients at sites that cannot implement take-home dosing changes or who do not qualify for take-home options may not benefit.

What this research studies

This study will test new, steadier clinic workflows that allow patients to take methadone home more often, aiming to keep them connected to care. It uses a stepped-wedge design across clinics to see how changes in policies affect retention and life quality. Participants are people enrolled in opioid treatment programs who could benefit from easier take-home dosing. The project will also explore safety concerns and how clinics adapt to new guidelines. Results could show practical ways to improve access to care while maintaining safety.

Why it matters

Potential benefit: If successful, patients could stay in treatment longer with fewer clinic visits, improving health and well-being.

How similar studies have gone: Prior regulatory changes suggesting benefit to retention exist, but more data-driven, clinic-level implementations are needed.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Neighbors, Charles J — New York University School of Medicine
  • Study coordinator: Neighbors, Charles J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.